Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-03-01 @ 10:02 AM
Study NCT ID:
NCT01203020
Status:
COMPLETED
Last Update Posted:
2023-07-13
First Post:
2010-09-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
Sponsor:
Organization: